Eagle Pharmaceuticals Reports Positive Outcome From FDA Meeting For RYANODEX For Exertional Heat Stroke NDA Submission
Go back to Eagle Pharmaceuticals Reports Positive Outcome From FDA Meeting For RYANODEX For Exertional Heat Stroke NDA Submission| EAGLE PHARMACEUT (NASDAQ: EGRX) | Delayed: 2.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.14 | 52 Week High | $102.48 | |||
| Open | $2.14 | 52 Week Low | $33.02 | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $2.14 | EPS | $-1.02 | |||
| Volume | 215 | |||||
